Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients
  2. Radtke, Andrea J; Postovalova, Ekaterina; Varlamova, Arina; Bagaev, Alexander; Sorokina, Maria; Kudryashova, Olga; Meerson, Mark; Polyakova, Margarita; Galkin, Ilia; Svekolkin, Viktor; Isaev, Sergey; Wiebe, Daniil; Sharun, Anna; Sarachakov, Alexander; Perelman, Grigory; Lozinsky, Yaroslav; Yaniv, Ziv; Lowekamp, Bradley C; Speranza, Emily; Yao, Li; Pittaluga, Stefania; Shaffer, Arthur L; Jonigk, Danny; Phelan, James D; Davies-Hill, Theresa; Huang, Da Wei; Ovcharov, Pavel; Nomie, Krystle; Nuzhdina, Ekaterina; Kotlov, Nikita; Ataullakhanov, Ravshan; Fowler, Nathan; Kelly,Michael; Muppidi, Jagan; Davis, Jeremy L; Hernandez, Jonathan M; Wilson, Wyndham H; Jaffe, Elaine S; Staudt, Louis M; Roschewski, Mark; Germain, Ronald N
  3. Cancer Cell. 2024, Feb 21; 42
  1. 2.   PIK3Cd expression by fibroblasts promotes triple-negative breast cancer progression
  2. Gagliano, Teresa; Shah, Kalpit; Gargani, Sofia; Lao, Liyan; Alsaleem, Mansour; Chen, Jianing; Ntafis, Vasileios; Huang, Penghan; Ditsiou, Angeliki; Vella, Viviana; Yadav, Kritika; Bienkowska, Kamila; Bresciani, Giulia; Kang, Kai; Li, Leping; Carter, Philip; Benstead-Hume, Graeme; O'Hanlon,Tim; Dean,Michael; Pearl, Frances Mg; Lee, Soo Chin; Rakha, Emad A; Green, Andrew R; Kontoyiannis, Dimitris L; Song, Erwei; Stebbing, Justin; Giamas, Georgios
  3. The Journal of clinical investigation. 2020, JUN 1; 130(6): 3188-3204.
  1. 3.   IKKa inactivation promotes Kras-initiated lung adenocarcinoma development through disrupting major redox regulatory pathways
  2. Song, Na-Young; Zhu, Feng; Wang, Zining; Willette Brown, Jami; Xi, Sichuan; Sun, David; Su, Ling; Wu, Xiaolin; Ma, Buyong; Nussinov, Ruth; Xia, Xiaojun; Schrump, David S; Johnson, Peter; Karin, Michael; Hu, Yinling
  3. Proceedings of the National Academy of Sciences of the United States of America. 2018, Jan 23; 115(4): E812-E821.
  1. 4.   Phenotype and functional characterization of long-term gp100-specific memory CD8(+) T cells in disease-free melanoma patients before and after boosting immunization
  2. Walker, E. B.; Haley, D.; Petrausch, U.; Floyd, K.; Miller, W.; Sanjuan, N.; Alvord, G.; Fox, B. A.; Urba, W. J.
  3. Clinical Cancer Research. 2008 14(16): 5270-5283.
  1. 5.   Identification of a unique epigenetic sub-microenvironment in prostate cancer
  2. Rodriguez-Canales, J.; Hanson, J. C.; Tangrea, M. A.; Erickson, H. S.; Albert, P. S.; Wallis, B. S.; Richardson, A. M.; Pinto, P. A.; Linehan, W. M.; Gillespie, J. W.; Merin, M. J.; Libutti, S. K.; Woodson, K. G.; Emmert-Buck, M. R.; Chuaqui, R. F.
  3. Journal of Pathology. 2007, Mar; 211(4): 410-419.
  1. 6.   Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity
  2. Kong, D. H.; Park, E. J.; Stephen, A. G.; Calvani, M.; Cardellina, J. H.; Monks, A.; Fisher, R. J.; Shoemaker, R. H.; Melillo, G.
  3. Cancer Research. 2005, OCT 1; 65(19): 9047-9055.
  1. 7.   Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappa B/p65 DNA binding
  2. Hu, J.; Colburn, N. H.
  3. Molecular Cancer Research. 2005, FEB; 3(2): 100-109.
  1. 8.   Induction of apoptosis by flavopiridol in human neuroblastoma cells is enhanced under hypoxia and associated with N-myc proto-oncogene down-regulation
  2. Puppo, M.; Pastorino, S.; Melillo, G.; Pezzolo, A.; Varesio, L.; Bosco, M. C.
  3. Clinical Cancer Research. 2004, DEC 15; 10(24): 8704-8719.
  1. 9.   5-Lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking
  2. Catalano, A.; Caprari, P.; Soddu, S.; Procopio, A.; Romano, M.
  3. Faseb Journal. 2004, SEP; 18(12): Published online only.
  1. 10.   Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects
  2. Reilly, K. M.; Tuskan, R. G.; Christy, E.; Loisel, D. A.; Ledger, J.; Bronson, R. T.; Smith, C. D.; Tsang, S.; Munroe, D. J.; Jacks, T.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004, AUG 31; 101(35): 13008-13013.
  1. 11.   Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation
  2. Dhar, A.; Hu, J.; Reeves, R.; Resar, L. M. S.; Colburn, N. H.
  3. Oncogene. 2004 23(25): 4466-4476.
  1. 12.   Angiogenic effects of prostaglandin E-2 are mediated by up- regulation of CXCR4 on human microvascular endothelial cells
  2. Salcedo, R.; Zhang, X.; Young, H. A.; Michael, N.; Wasserman, K.; Ma, W. H.; Martins-Green, M.; Murphy, W. J.; Oppenheim, J. J.
  3. Blood. 2003 102(6): 1966-1977.
  1. 13.   Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses
  2. Salcedo, R.; Oppenheim, J. J.
  3. Microcirculation. 2003 10(3-4): 359-370.
  1. 14.   Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells
  2. Firon, M.; Shaharabany, M.; Altstock, R. T.; Horev, J.; Abramovici, A.; Resau, J. H.; Vande Woude, G. F.,; Tsarfaty, I.
  3. Oncogene. 2000 19(20): 2386-2397.
  1. 15.   Induction of proliferative lesions of the uterus, testes, and liver in Swiss mice given repeated injections of sodium arsenate: Possible estrogenic mode of action
  2. Waalkes, M. P.; Keefer, L. K.; Diwan, B. A.
  3. Toxicology and Applied Pharmacology. 2000 166(1): 24-35.
  1. 16.   The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma
  2. Green, J. E.; Shibata, M. A.; Yoshidome, K.; Liu, M. L.; Jorcyk, C.; Anver, M. R.; Wigginton, J.; Wiltrout, R.; Shibata, E.; Kaczmarczyk, S.; Wang, W.; Liu, Z. Y.; Calvo, A.; Couldrey, C.
  3. Oncogene. 2000 19(8 Special Issue SI): 1020-1027.
  1. 17.   Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage
  2. Shibata, M. A.; Liu, M. L.; Knudson, M. C.; Shibata, E.; Yoshidome, K.; Bandey, T.; Korsmeyer, S. J.; Green, J. E.
  3. Embo Journal. 1999 18(10): 2692-2701.
  1. 18.   Reversal of hypercalcemia with the vitamin D analogue EB1089 in a human model of squamous cancer
  2. El Abdaimi, K.; Papavasiliou, V.; Rabbani, S. A.; Rhim, J. S.; Goltzman, D.; Kremer, R.
  3. Cancer Research. 1999 59(14): 3325-3328.
  1. 19.   Tpl-2 Is an Oncogenic Kinase That Is Activated By Carboxy-Terminal Truncation
  2. Ceci, J. D.; Patriotis, C. P.; Tsatsanis, C.; Makris, A. M.; Kovatch, R.; Swing, D. A.; Jenkins, N. A.; Tsichlis, P. N.; Copeland, N. G.
  3. Genes & Development. 1997 11(6): 688-700.
  1. 20.   Reduced P53 Dosage Associated With Mammary Tumor Metastases in C3(1)/T-Ag Transgenic Mice
  2. Maroulakou, I. G.; Shibata, M. A.; Jorcyk, C. L.; Chen, X. X.; Green, J. E.
  3. Molecular Carcinogenesis. 1997 20(2): 168-174.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel